메뉴 건너뛰기




Volumn 22, Issue 6, 2000, Pages 9-11

The IRB is not a data and safety monitoring board

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; GOVERNMENT REGULATION; HUMAN; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; STANDARD;

EID: 0034334228     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: 10.2307/3563586     Document Type: Article
Times cited : (12)

References (7)
  • 1
    • 9444278306 scopus 로고    scopus 로고
    • Washington, D.C.: DHHS
    • Department of Health and Human Services, Office of Inspector General. Instititional Review Boards: A Time for Reform. Washington, D.C.: DHHS, 1998:4.
    • (1998) Instititional Review Boards: A Time for Reform , pp. 4
  • 3
    • 9444258496 scopus 로고    scopus 로고
    • Director of the Division of Scientific Investigations, Food and Drug Administration, personal communication, 23 Oct
    • P. Goebel, Director of the Division of Scientific Investigations, Food and Drug Administration, personal communication, 23 Oct 1998.
    • (1998)
    • Goebel, P.1
  • 4
    • 9444296437 scopus 로고
    • 5 June
    • NIH Policy for Data and Safety Monitoring, 10 June 1998. Reaffirms 1979 NIH Guide, Volume 8, No. 8, 5 June 1979.
    • (1979) Reaffirms 1979 NIH Guide , vol.8 , Issue.8
  • 7
    • 0031261128 scopus 로고    scopus 로고
    • IRB review of adverse events in investigational drug studies
    • Prentice ED, Gordon B.: IRB review of adverse events in investigational drug studies. IRB 1997:19(6):1-4.
    • (1997) IRB , vol.19 , Issue.6 , pp. 1-4
    • Prentice, E.D.1    Gordon, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.